Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris

Figure 3

Anti-MCV titers are higher in severe PsO patients treated with biological therapy than in moderate-to-severe psoriasis patients not requiring biological therapy. The plots show the antibody levels of investigated patients. The horizontal lines indicate the mean levels of anti-MCVs. *The PsO patients not requiring biological therapy had significantly lower anti-MCV levels than those treated with biological therapy (3.01±3.34 U/mL versus 14.01±6.22 U/mL; 𝑃<0.01).